Lucid Diagnostics Inc.
LUCD · NASDAQ
Bulios Fair Price
$1.14
45.7% upside
Trenutna cena
$0.78
Po podatkih Bulios Fair Price je delnica LUCD trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
Lucid Diagnostics Inc. is a biotechnology company focused on developing diagnostic technologies and tests. The company specializes in diagnostics and disease detection, particularly in the field of gastroenterology. Lucid Diagnostics develops advanced diagnostic tests and devices that enable precise and rapid determination of patients' conditions and identification of potential diseases. The company emphasizes research and development to provide the medical industry with innovative tools and technologies to improve diagnostics and patient care. Lucid Diagnostics aims to contribute to better health outcomes and quality of life for patients through its diagnostic innovations. Lucid Diagnostics Inc. shares may be an attractive investment opportunity for investors interested in the biotechnology sector and seeking an investment in a company focused on the development of diagnostic technologies with the potential to enhance medical care.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Medical - Devices
CEO
Lishan Aklog
Employees
82
Headquarters
New York City
Prihajajoči dogodki
Earnings
Upcoming earnings report